HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
Status:
Recruiting
Trial end date:
2028-10-31
Target enrollment:
Participant gender:
Summary
This is a Multi-center, Open-label, Single-arm Phase II Study to Evaluate the Efficacy and
Safety of HL-085 in the treatment of Adult Participants with Neurofibromatosis Type 1 (NF1)
and Inoperable Plexiform Neurofibromas(PN)